- Report
- February 2024
- 135 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- April 2018
Global
From €965EUR$1,000USD£828GBP
- Report
- April 2023
- 95 Pages
Global
€3378EUR$3,500USD£2,898GBP
Zomig is a brand of medication used to treat migraine headaches. It belongs to a class of drugs known as triptans, which are used to treat moderate to severe migraine pain. Zomig works by narrowing blood vessels around the brain, reducing inflammation and relieving pain. It is available in both oral and nasal spray forms. Zomig is one of the most commonly prescribed medications for migraine headaches, and is part of the larger Central Nervous System (CNS) drug market. CNS drugs are used to treat a variety of neurological conditions, including depression, anxiety, and epilepsy.
The CNS drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the Zomig market include GlaxoSmithKline, Merck, Pfizer, and Novartis. Other companies, such as Teva Pharmaceuticals and Mylan, also produce generic versions of Zomig. Show Less Read more